logo
Select company
Select metric
$ -1.13MConsolidated Income
VS
Market
44
Sector
79
Industry
91
History
88
$ 1Close
$ 0.83 - $ 1.92 52-Week Range
Ticker Information

Ticker

PMCB

Company Name

PHARMACYTE BIOTECH INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PHARMACYTE BIOTECH INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PMCB - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -1.13M
3/31/2025$ 30.66M
12/31/2024$ 20.25M
9/30/2024$ 22.68M
6/30/2024$ 26.94M
3/31/2024$ 333.76K
12/31/2023$ -1.14M
9/30/2023$ -1.28M
6/30/2023$ -5.95M
3/31/2023$ -4.32M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PHARMACYTE BIOTECH INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -3.46M.
  • Over the past 5 years, PHARMACYTE BIOTECH INC's average Cons. Inc. has been $ 2.26M.
  • The median Cons. Inc. for PHARMACYTE BIOTECH INC during this period was $ -3.51M
  • PHARMACYTE BIOTECH INC reached its highest Cons. Inc. over the past 5 years at $ 30.66M.
  • The lowest Cons. Inc. recorded by PHARMACYTE BIOTECH INC in the same timeframe $ -5.95M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

PMCB - Consolidated Income, Last 5 years

$ -5.95M

Minimum

Jun 30, 2023

$ 30.66M

Maximum

Mar 31, 2025

$ 2.26M

Average

$ -3.51M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.09M with a standard deviation of $ 116.52M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.09M
median$ -2.07M
std$ 116.52M